Cyfra 21-1 and TPA as markers in malignant mesothelioma

被引：0
|
作者：
Bonfrer, JMG
Schouwink, JH
Korse, CM
Baas, P
机构：
[1] OLVG HOSP,DEPT PULMONOL,NL-1091 HA AMSTERDAM,NETHERLANDS
[2] NETHERLANDS CANC INST,ANTONI VAN LEEUWENHOEK HUIS,DEPT MED ONCOL,NL-1066 CX AMSTERDAM,NETHERLANDS
来源：
ANTICANCER RESEARCH | 1997年 / 17卷 / 4B期
关键词：
Cyfra; 21-1; TPA; malignant mesothelioma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Serum concentrations of CEA and Cyfra were compared in patients with mesothelioma. Materials and Methods: Serum levels of patients were analysed for prognosis of survival and follow up of disease. Results: Cyfra 21-1 and TPA have significant prognostic value for survival. Conclusion: Assays measuring CK19 fragments seem to be good markers in the management of patients with malignant mesothelioma.
引用
收藏
页码：2971 / 2973
页数：3
相关论文
共 50 条
  • [1] Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma
    Schouwink, H
    Korse, CM
    Bonfrer, JMG
    Hart, AAM
    Baas, P
    LUNG CANCER, 1999, 25 (01) : 25 - 32
  • [2] CYFRA 21-1 in the follow-up of patients with malignant pleural mesothelioma
    Berzinec, P
    Zuffova, H
    LUNG CANCER: CURRENT TOPICS, 2001, : 31 - 36
  • [3] The usefulness of CYFRA 21-1 in diagnosing and monitoring malignant pleural mesothelioma
    Marukawa, M
    Hiyama, J
    Shiota, Y
    Ono, T
    Sasaki, N
    Taniyama, K
    Mashiba, H
    ACTA MEDICA OKAYAMA, 1998, 52 (02) : 119 - 123
  • [4] Comparison of Cyfra 21-1, TPA and SCC tumor markers in esophageal squamous cell carcinoma
    Quillien, V
    Raoul, JL
    Laurent, JF
    Meunier, B
    Le Prise, E
    ONCOLOGY REPORTS, 1998, 5 (06) : 1561 - 1565
  • [5] Cytokeratins as serum markers in Egyptian bladder cancer. A comparison of CYFRA 21-1, TPA and TPS
    Mady, EA
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2001, 16 (02) : 130 - 135
  • [6] Evaluation of CYFRA 21-1 in malignant and benign pleural effusions
    Toumbis, M
    Rasidakis, A
    Passalidou, E
    Kalomenidis, J
    Alchanatis, M
    Orphanidou, D
    Jordanoglou, J
    ANTICANCER RESEARCH, 1996, 16 (4A) : 2101 - 2104
  • [7] Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer
    Stieber, P
    Schmeller, N
    Schambeck, C
    Hofmann, K
    Reiter, W
    Hasholzner, U
    FatehMoghadam, A
    ANTICANCER RESEARCH, 1996, 16 (6B) : 3793 - 3798
  • [8] CYFRA 21-1: AN OVERVIEW
    Jose, Jithin
    Sunil, P. M.
    Nirmal, R. Madhavan
    Varghese, Soma Susan
    ORAL & MAXILLOFACIAL PATHOLOGY JOURNAL, 2013, 4 (02) : 368 - 371
  • [9] Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer
    Gaarenstroom, KN
    Bonfrer, JMG
    Korse, CM
    Kenter, GG
    Kenemans, P
    ANTICANCER RESEARCH, 1997, 17 (4B) : 2955 - 2958
  • [10] The diagnostic value of Cyfra 21-1, CEA, TPS, TPA-M® and NSE in NSCLC
    Golab, T
    Brulinski, K
    Malinowski, E
    Slowinska-Primus, B
    Kucharz, EJ
    Aronsson, AC
    Smiarowski, A
    Braclik, M
    EFIS 2000: 14TH EUROPEAN IMMUNOLOGY MEETING, 2000, : 811 - 814
12345